Ibex Investors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,260	Closed	-$216K	–	204
2018 Q3	$216K	Buy	+1,260	New	+$216K	0.12%	74